XM does not provide services to residents of the United States of America.
S
S

SWI20Cash

News

Swiss stocks - Factors to watch on November 22

Swiss stocks - Factors to watch on November 22 ZURICH/GDANSK, Nov 22 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday: ANALYSTS' VIEWS LINDT & SPRUENGLI LISN.S - BAADER HELVEA CUTS TARGET PRICE TO CHF 10,700 FROM CHF 11,200, RAISES TO ADD FROM REDUCE ECONOMY No major Swiss economic data scheduled. Reporting by Zu
S

Zurich Insurance at nearly 24-year high as targets record EPS growth in mid-term

BUZZ-Zurich Insurance at nearly 24-year high as targets record EPS growth in mid-term ** Shares in Zurich Insurance ZURN.S rise 2.1% to their highest price since March 2001 after Europe's fifth-largest insurer announced its three-year targets ** Zurich Insurance set goals for a core return on equity of more than 23% between 2025 and 2027, as well a
J
Z
S

Swiss stocks - Factors to watch on November 21

Swiss stocks - Factors to watch on November 21 ZURICH/GDANSK, Nov 21 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: ZURICH INSURANCE GROUP AG ZURN.S Europe's fifth-largest insurer Zurich Insurance unveiled its targets for the next three years on Thursday, aiming to reach average annual growth of more than 9% in its core earnings per share.
N
S
J
Z
S

Zurich Insurance raises return on equity targets, shares hit 23-year high

UPDATE 3-Zurich Insurance raises return on equity targets, shares hit 23-year high Adds share price reaction in paragraphs 1,7 ZURICH, Nov 21 (Reuters) - Zurich Insurance ZURN.S on Thursday raised return on equity targets and committed to achieving average annual growth of more than 9% in core earnings per share, sending its shares to a 23-year high.
Z
S

Swiss stocks - Factors to watch on November 20

Swiss stocks - Factors to watch on November 20 ZURICH/GDANSK, Nov 20 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday: COMPANY STATEMENTS SGS SA SGSN.S Fully confirms 2024 outlook and 2024-2027 financial objectives. ANALYSTS' VIEWS AVOLTA AG AVOL.S - JP MORGAN CUTS TARGET PRICE TO CHF 50 FROM CHF 60 ECONOMY No major Swiss economic data scheduled.
S
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.